Asthma Educator (AE-C) Re-credentialing Package

Asthma is a reversible disease requiring appropriate pharmacological treatment by the Respiratory Therapist.

This presentation will cover existing and new aerosolized medications recommended by national and international guidelines in both acute and maintenance treatment of the disease.

• Approved for 1.0 CRCE

Speaker Information

• Douglas S. Gardenhire EdD, RRT, RRT-NPS, FAARC

This presentation focuses on high-impact education that addresses individual self-care needs that are uncovered by EPR3-compliant assessments, including patient access to and use of medications (adherence), adequacy of inhalation technique, recognition and avoidance of environmental triggers, self-monitoring routines, and readiness for managing asthma emergencies.

• Approved for 1.0 CRCE

Speaker Information

• Ben Francisco, PhD, PNP, AE-C

Respiratory therapists play a significant role in the treatment and management of asthma. This course, updated in 2021 with new content, addresses the pathophysiology and diagnosis of asthma, measures of assessment and monitoring, pharmacologic therapy, impact of social determinants of health on asthma outcomes, control of environmental factors, and comorbid conditions that affect asthma.

• Approved for 3.5 CRCE

Speaker Information

• Douglas S. Gardenhire EdD, RRT, RRT-NPS, FAARC
• Ellen A. Becker PhD, RRT, RRT-NPS, RPFT, AE-C, FAARC
• Shawna Strickland, PhD, CAE, RRT, RRT-NPS, RRT-ACCS, AE-C, FAARC

According to the Centers for Disease Control and Prevention, asthma is one of the leading causes of school absenteeism in the United States. The respiratory therapist has a unique role in not only the diagnosis and treatment of asthma but also in helping patients and families develop good asthma self-management skills to prevent the negative impact of asthma, including school absenteeism. This presentation will discuss asthma and its impact on student absenteeism, the role of the AAP as a surveillance tool in school districts and the importance of students with asthma having an AAP on record.

• Approved for 1.0 CRCE

Speaker Information

• De De Gardner, DrPH, RRT, RRT-NPS, FAARC

The speaker will discuss the manuscript published in the October 2020 issue of RESPIRATORY CARE: “Clinical Efficacy of Vibrating Mesh and Jet Nebulizers with Different Interfaces in the Pediatric Asthma Patient.” The presentation will focus on the research design and interpretation of the results.

• Approved for 1.0 CRCE

Speaker Information

• Natalie Napolitano MPH, RRT, RRT-NPS, FAARC

This program will present the issues respiratory therapists address when implementing an asthma disease management program in a variety of sites. These include needs assessment, objectives, educational methodologies, reimbursement strategies, outcomes and evaluation.

• Approved for 1.0 CRCE

Speaker Information

• Joyce Baker, MBA, RRT, RRT-NPS, AE-C

In this presentation the speaker will discuss the Editor’s Choice of the March 2022 issue of RESPIRATORY CARE “Endotracheal Tube Size is Associated with Mortality in Subjects with Status Asthmaticus”. The presentation will focus on the research design and interpretation of the results.

• Approved for 1.0 CRCE

Speaker Information

• Presenter:
  • Karsten Roberts MSc, RRT, RRT-ACCS, FAARC
• Moderator:
  • Julie Jackson BAS, RRT, RRT-ACCS

The speaker will discuss the Editor’s Choice of the September 2020 issue of RESPIRATORY CARE “Initial Modified Pulmonary Index Score Predicts Hospital Length of Stay for Pediatric Asthma Patients Admitted to the Pediatric Intensive Care Unit”. The presentation focuses on the research design and interpretation of the results.

• Approved for 1.0 CRCE

Speaker Information

• Dana Evans MHA, RRT, RRT-NPS, FACHE